iBalt Brazil L +4

Throughout its history, Balt has been at the forefront of innovation in the field of Interventional Neuroradiology.



Today, the breadth of its products portfolio echoes the expertise the company has built up over several decades. It is important for Balt to present its assets to Healthcare professionals via a single mobile application: iBalt.



The iBalt application combines technical information related to products usage, compatibilities & practical tools.



• The iBalt app presents Balt's portfolio : to inform about the compatibility of each Balt’s product, set up a secure private space for healthcare professionals and provide (restricted) access to technical product information.

• The iBalt app has a compatibility function : to find the inner diameters, outer diameters, and lengths of access products to make your day-to-day work easier.

• The iBalt app offers an easy-to-use unit’s converter : to instantly check the proper compatibilities of interventional neuroradiology devices in French, inch, and millimeter,



If you are a healthcare professional you can register to the app and sign in to have access to restricted information.



The application has an off-line functionality, you can use it even without connection.



BALT is one of the world leader in the design and manufacture of Interventional Neuroradiology devices to treat neurovascular pathologies (strokes, aneurysms, arteriovenous malformations, etc.). By placing innovation at the center of its model, the company maintains its leading position in the Neuroradiology field worldwide.



The success of BALT relies on the originality of several key assets:

• Sustainable industry recognition and industrial partnerships to serve the healthcare community and patients.

• Strong and ongoing innovation to meet the expectations of the medical community: BALT’s many innovations are testimonies to the company’s major influence on the progress of Interventional Neuroradiology. They include the flow-dependent microcatheter (MAGIC, 1987), as well as the intracranial braided stent (LEO in 2003 and LEO+ in 2007 and LEO+Baby in 2012), the stentriever (CATCH in 2005, CATCH+ in 2012 and CATCHVIEW in 2018) and the flow-diverter (SILK in 2006, SILK+ in 2012, SILK VISTA BABY in 2018 and SILK VISTA in 2020).

• Multidisciplinary crossover talents: in its search for the highest performing neuroradiology products, BALT has always promoted a cross-innovation approach based on complementary expertise and disciplines. From chemistry to micromechanics, the production cycle is based on interdisciplinarity and constantly pursues end-product excellence.